Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02499328
Title Study to Assess Combination of MEDI4736 With Either AZD9150 or AZD5069 in Patients With Metastatic Squamous Cell Carcinoma of Head and Neck
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors AstraZeneca

oral squamous cell carcinoma

hypopharynx cancer

Advanced Solid Tumor

laryngeal squamous cell carcinoma

oropharynx cancer

head and neck squamous cell carcinoma


AZD9150 + Durvalumab

AZD5069 + Durvalumab



Age Groups: adult
Covered Countries USA | ITA | ESP | DEU | BEL

No variant requirements are available.